Two patients with primary pituitary insufficiency were treated with excessive doses of HMG only for 10 and 14 days. The 
It was confirmed that patients with primary pituitary insufficiency need a high dose of HMG (800 IU and 2560 IU FSH) before any oestrogen is excreted.
In spite of the extreme stimulation and the resulting high oestrogen excretion, the ovaries were not enlarged at any time during the observation period. It is concluded that the administration of both HMG and HCG is necessary for the development of a hyperstimulation syndrome. Furthermore, it was shown that the excretion of oestrogens continued to increase for a couple of days after the treatment with HMG was stopped. At the same time it was found that the excretion of total gonadotrophins remained elevated for about 8\p=n-\10 days after the last dose of HMG had been given. These findings indicate that HMG has a prolonged effect. Therefore, it has been proposed to change the commonly used scheme of treatment with HMG-HCG in such a manner that HGG is given 2\p=n-\3 days after the last dose of HMG in order to reduce the risk of hyperstimulation.
The observation of Johannisson et al. (1961) that the excretion of oestrogens in women with amenorrhoea is increased significantly and reaches a peak [10] [11] [12] [13] Johnsen (1958) , while the oestrogen excretion was 0 /(g/day (Brown et al. 1968 ). Exploratory laparotomy showed a small uterus (3X3X3 cm) and small ovaries (J X 1 X 4 cm). Ovarian biopsies revealed many unstimulated primordial follicles, no follicles in development and no corpora lutea.
At the age of 20 substitution therapy with cyclically administered oestrogen-gestagen was initiated, and during this treatment vaginal bleeding occurred, and a fair de¬ velopment of the secondary sex-characteristics occurred. (Brown et al. 1968 ) and pregnanediol (Klopper et al. 1955 ) was determined daily before, during and after the treatment with HMG. Moreover, the excretion of total gonadotrophins (Johnsen 1958 ) was determined on a few occasions in both patients after cessation of treatment. Finally, both patients had a pelvic examination every day during the whole observation period in order to determine the size of the ovaries and the amount of cervical mucus.
RESULTS
Figs. 1 and 2 show the daily urinary excretion of total oestrogens and preg¬ nanediol in the two patients before, during and after treatment with HMG.
In case no. 1 (Fig. 1) (Crooke et al. 1966) .
Our investigation confirmed the finding of Gemzell 8c Roos (1966) that patients with primary pituitary insufficiency need high doses of exogenous gonadotrophins to be stimulated, but also that in these patients there seems to be a great individual variation in the response, probably due to differences in the sensitivity of the ovaries.
Another interesting finding in the present study was that the excretion of total oestrogens continued to increase for 5 and 2 days respectively after the administration of HMG was discontinued, and then the excretion gradually decreased for the next 10-11 days, until the pre-treatment level was reached again. Furthermore, we were able to demonstrate the excretion of total gonadotrophins in the urine for about 8-10 days after the last dose of HMG had been given. These findings indicate that the further increase in the oestrogen excretion after treatment with HMG is discontinued is due to and can fully be explained by a prolonged effect of the exogenous administered FSH. 
